Plerixafor

CAS No. 110078-46-1

Plerixafor( JM-3100 | AMD-3100 | SID-791 )

Catalog No. M10387 CAS No. 110078-46-1

Plerixafor (JM-3100, AMD-3100, SID-791) is a potent, selective CXCR4 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 38 In Stock
10MG 57 In Stock
25MG 102 In Stock
50MG 161 In Stock
100MG 291 In Stock
200MG 462 In Stock
500MG 736 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Plerixafor
  • Note
    Research use only, not for human use.
  • Brief Description
    Plerixafor (JM-3100, AMD-3100, SID-791) is a potent, selective CXCR4 inhibitor.
  • Description
    Plerixafor (JM-3100, AMD-3100, SID-791) is a potent, selective CXCR4 inhibitor (IC50=44 nM) that inhibits the replication of various HIV-1 and HIV-2 strains in various cell lines with EC50 of 10ng/ml; can produce mesenchymal stem cells and endothelial progenitor cells in mice in combination with VEGF; also is an allosteric agonist of CXCR7.Blood Cancer Approved.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    JM-3100 | AMD-3100 | SID-791
  • Pathway
    GPCR/G Protein
  • Target
    Chemokine Receptor
  • Recptor
    CXCL12|CXCR4
  • Research Area
    Cancer
  • Indication
    Blood cancer

Chemical Information

  • CAS Number
    110078-46-1
  • Formula Weight
    502.782
  • Molecular Formula
    C28H54N8
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    C1(CN2CCNCCCNCCNCCC2)=CC=C(CN3CCNCCCNCCNCCC3)C=C1
  • Chemical Name
    1,4,8,11-Tetraazacyclotetradecane, 1,1'-[1,4-phenylenebis(methylene)]bis-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zabel BA, et al. J Immunol. 2009, 183(5), 3204-3211. 2. De Clercq E, et al. Antimicrob Agents Chemother. 1994 Apr;38(4):668-74. 3. Pitchford SC, et al. Cell Stem Cell. 2009 Jan 9;4(1):62-72.
molnova catalog
related products
  • GSK812397

    GSK812397 is a potent, selective, noncompetitive, orally available antagonist of CXCR4 receptor.

  • BMS-22

    A potent, selective, allosteric CCR2 antagonist with binding IC50 of 5.1 nM.

  • AZD 1678

    AZD 1678 is a potent, selective orally bioavailable CCR4 receptor antagonist with pIC50 of 8.6 for hCCR4, pIC50 of 9.0 for rCCR4.